Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology, Trends in Formulation, October 2022, Volume 2022 eBook, Issue 3
Pages: 4–9

An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.

Time-to-market remains a significant factor in drug development today, as delays in timelines can often have costly and damaging effects, not only to the drug developer but to the patient. Challenges in the drug development cycle arise early in the drug candidate screening process. In this article, Industry players discuss how technological innovation and advances in analytical approaches enhance early drug candidate screening workflows to help shorten drug discovery and development timelines.

Read this article in Pharmaceutical Technology’s October 2022 Trends in Formulation eBook.


About the author

Feliza Mirasol is science editor for Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Trends in Formulation, October 2022
October 2022
Pages: 4–9


When referring to this article, please cite it as F. Mirasol, “Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk," Pharmaceutical Technology Trends in Formulation eBook (October 2022).